Genocea Biosciences reported $-15373000 in EBITDA for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Agenus AGEN:US $ -34.34M 20.08M
Baxter International BAX:US $ 911M 27M
Cytokinetics CYTK:US $ -76.52M 58.35M
Cytori Therapeutics CYTX:US $ -3.78M 0.27M
Genocea Biosciences GNCA:US $ -15.37M 2.37M
Glaxosmithkline GSK:US $ 3120M 1062M
Infinity Pharmaceuticals INFI:US $ -12.29M 0.91M
Merk MRK:US $ 6179M 492M
Mirati Therapeutics MRTX:US $ -183.59M 12.92M
Moderna Inc MRNA:US 4.31B 1.18B
Novavax NVAX:US $ 216.06M 1037.12M
Pfizer PFE:US $ 11182M 4046M
Prothena PRTA:US -37744000 4.89M